Rockwell Medical, Inc. (RMTI)

1,4600 -0,0200 (-1,35%) In data: 02:19PM EDT. Mercato aperto.

Rockwell Medical, Inc.

30142 South Wixom road
Wixom, MI 48393
United States
248 960 9009
https://www.rockwellmed.com

Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 237

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. Mark Strobeck Ph.D.	President, CEO & Director	904,66k	N/D	1971
Mr. Jesse Neri	Senior Vice President of Finance	359,63k	N/D	1978
Ms. Megan C. Timmins	Executive VP, Chief Legal Officer & Secretary	585,74k	N/D	1973
Mr. James A. McCarthy	Senior Vice President of Business & Corporate Development	N/D	N/D	N/D
Mr. Timothy T. Chole	Senior Vice President of Sales & Marketing	N/D	N/D	N/D
Ms. Heather R. Hunter	Senior VP & Chief Corporate Affairs Officer	N/D	N/D	N/D
Mr. Jason Finkelstein	Investor Relations Representative	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Governance aziendale

L'ISS Governance QualityScore di Rockwell Medical, Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.